(Hypertension. 1996;28:315-319.)
© 1996 American Heart Association, Inc.
Articles |
An E-Box Motif Conveys Inhibitory Activity on the Atrial Natriuretic Peptide Gene
the Metabolic Research Unit and Department of Medicine, University of California at San Francisco.
Correspondence to David G. Gardner, MD, Metabolic Research Unit, University of California, Box 0540 1142 HSW, San Francisco, CA 94143.
Atrial natriuretic peptide (ANP) is a potent diuretic, natriuretic, and vasorelaxant hormone that is expressed early in ventricular hypertrophy. Expression of human ANP is controlled by a series of regulatory elements located in the 5' flanking sequence of its gene. We generated a series of 5' deletion mutations extending from -2600 to -1150 relative to the transcription start site and linked them to a chloramphenicol acetyltransferase reporter gene. Using transient transfection analysis, we have identified a negative regulatory element between -1206 and -1152 relative to the start site. Each of a series of 5' deletion mutants, when introduced into fibroblast cultures, expressed the reporter function at a level that was significantly less (<20%) than that seen with the -1152 reporter construct, whereas comparably transfected atrial cardiocytes demonstrated no change in reporter activity, implying that the repressor function is specific to cell type. The critical region (from -1206 to -1152) associates with a soluble protein present in cardiac fibroblast extracts in a sequence-specific fashion. Deoxyribonuclease I footprint analysis demonstrated the presence of several protected regions, including one that overlies an E-box motif (CAACTG), an element that in other systems has been implicated in promoting differentiation in the myocyte lineage. Site-directed mutagenesis of the E-box motif suppressed both the protein-binding and inhibitory activities of the 54-bp fragment. In summary, we have found a region in the 5' flanking sequence of the human ANP gene that represses transcriptional activity in nonmyocardial cells. This element may play an important role in the restriction of ANP gene expression to cardiac myocytes.
Key Words: natriuretic peptides • gene expression
This article has been cited by other articles:
 |
|
 |
|
  D. G. Gardner, S. Chen, D. J. Glenn, and C. L. Grigsby Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension Hypertension, March 1, 2007; 49(3): 419 - 426. [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-G. V. Nguyen, J. N. Buskin, C. L. Himeda, M. A. Shield, and S. D. Hauschka Differences in the Function of Three Conserved E-boxes of the Muscle Creatine Kinase Gene in Cultured Myocytes and in Transgenic Mouse Skeletal and Cardiac Muscle J. Biol. Chem., November 21, 2003; 278(47): 46494 - 46505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C Kone Molecular biology of natriuretic peptides and nitric oxide synthases Cardiovasc Res, August 15, 2001; 51(3): 429 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Cameron, M. T. Rademaker, L. J. Ellmers, E. A. Espiner, M. G. Nicholls, and A. M. Richards Atrial (ANP) and Brain Natriuretic Peptide (BNP) Expression after Myocardial Infarction in Sheep: ANP Is Synthesized by Fibroblasts Infiltrating the Infarct Endocrinology, December 1, 2000; 141(12): 4690 - 4697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Majalahti-Palviainen, M. Hirvinen, V. Tervonen, M. Ilves, H. Ruskoaho, and O. Vuolteenaho Gene Structure of a New Cardiac Peptide Hormone: A Model for Heart-Specific Gene Expression Endocrinology, February 1, 2000; 141(2): 731 - 740. [Abstract] [Full Text] [PDF]
|
|